New Mycoplasmasynoviae vaccine enters development

11-02-2019 | | |
Photo: Shutterstock
Photo: Shutterstock

UK-headquartered ECO Animal Health is to begin development of a live attenuated Mycoplasmasynoviae vaccine for poultry after signing a second agreement with the University of Georgia.

It follows a similar arrangement between the university and ECO Animal Health for potential vaccines in the field of Mycoplasma gallisepticum.

Researchers at the university have concluded preliminary proof-of-concept for both efficacy and safety for the new vaccine.

Peter Lawrence, Non-Executive Chairman of ECO Animal Health Group plc said, “Mycoplasmasynoviae is a bacterium that affects predominately commercial layers and breeding birds worldwide resulting in a 5%-10% loss in egg production and lower egg quality in affected flocks.”

UGA Professor Naola Ferguson-Noel, a researcher in the Poultry Diagnostic & Research Center said, “We look forward to working with ECO Animal Health to help further develop this Mycoplasma synoviae vaccine into an approved product.”

Davies
Jake Davies Freelance Journalist
More about



Beheer